FY2025 · ended Dec 31, 2025 · Revenue $311.14M, +1.5% YoY · Filed Mar 12, 2026
Health Catalyst, Inc. (HCAT) files with the SEC under industry code 7370, Services-Computer Programming, Data Processing, Etc. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $311.1 million and a net loss of $178.0 million. Free cash flow was -$237,000. As of Jun 30, 2026 it held $103.4 million in cash and investments and $170.0 million in total debt.
Revenue (TTM)
$292.25M
-7.5% vs year-ago TTM
Net income (TTM)
$-264.82M
-164.5% vs year-ago TTM
Operating cash flow (TTM)
$28.23M
+567.8% vs year-ago TTM
Free cash flow (TTM)
$27.02M
+455.8% vs year-ago TTM
EPS (TTM)
$-3.68
-139.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
73.59M
+0.0% vs prior year
Net cash
$-66.54M
as of Jun 30, 2026
Operating margin
-84.4%
FY 2026
Company profile
- Industry
- Services-Computer Programming, Data Processing, Etc. (SIC 7370)
- Listed as
- HCAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South Jordan, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1636422
- Former names
- HQC Holdings, Inc. (until Feb 19, 2016)
Other Services-Computer Programming, Data Processing, Etc. companies
- Alphabet Inc. GOOGL
- Meta Platforms, Inc. META
- AppLovin Corp APP
- Nebius Group N.V. NBIS
- Bending Spoons S.p.A. BSP
- Zoom Communications, Inc. ZM
- Baidu, Inc. BIDU
- Flutter Entertainment plc FLUT
All 94 Services-Computer Programming, Data Processing, Etc. companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M |
| Operating income | -$160.9M | -$69.8M | -$126.9M | -$140.0M | -$143.7M |
| Net income | -$178.0M | -$69.5M | -$118.1M | -$137.4M | -$153.2M |
| Diluted EPS | -$2.55 | -$1.15 | -$2.09 | -$2.63 | -$3.23 |
| Operating cash flow | $731,000 | $14.6M | -$33.1M | -$35.3M | -$23.1M |
| Free cash flow | -$237,000 | $12.9M | -$34.3M | -$37.4M | -$33.6M |
| Total assets | $502.6M | $858.9M | $701.8M | $752.3M | $832.1M |
| Total liabilities | $256.9M | $493.7M | $334.9M | $327.3M | $310.0M |
| Stockholders' equity | $245.8M | $365.2M | $366.9M | $425.0M | $522.1M |
| Cash and investments | $95.7M | $392.0M | $317.7M | $363.5M | $445.0M |
| Total debt | $171.2M | $402.3M | $249.1M | $248.0M | $204.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 14, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 4, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 20, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 4, 2026 | Jun 4, 2026 |
All 933 Health Catalyst, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.